Video Review: Talking Biopolitics
By Rebecca Dimond,
BioNews
| 10. 12. 2015
[cites CGS and CGS fellow Lisa Ikemoto]
Untitled Document
Watch Talking Biopolitics with George Annas and Lisa Ikemoto on YouTube
Genomic medicine has advanced rapidly in recent years and, with our increasing capacity to collect and store genetic information, it holds not only great promise but also pitfalls, for individuals and communities. This was the topic under discussion in a live video conversation on 7 October, organised by the Center for Genetics and Society.
The conversation was between Professor Lisa Ikemoto of the University of California, who was interviewing Professor George Annas, Director of the Center of Health Law, Ethics and Human Rights at Boston University, about his book Genomic Messages: How the Evolving Science of Genetics Affects our Health, Families, and Future'.
Professor Annas and his co-writer Sherman Elias (an obstetrician-gynaecologist, who died last year) have written a book that addresses important issues. The blurb on the back refers to 'an uncertain time' and one that is 'fraught with understandable and uncomfortable questions'. So I was intrigued to discover what topics the conversation would cover, and what 'uncomfortable questions' it might address.
Professor Annas...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...